The United Bio-technology (hengqin) Co., Ltd.

This study is testing an investigational injection called UBT251 to see if it can improve liver health in adults with Metabolic Dysfunction-Associated Steatohepatitis (MASH), a serious form of fatty liver disease. About 156 participants will receive either UBT251 at one of three …

This study is testing whether an experimental injection called UBT251 can help protect kidney function and reduce body weight in adults who are overweight or obese and have chronic kidney disease. About 180 participants will receive either the UBT251 injection or a placebo (dummy…